Literature DB >> 26778646

A pre-treatment quality assurance survey on 384 patients treated with helical intensity-modulated radiotherapy.

Sara Bresciani1, Anna Miranti2, Amalia Di Dia2, Angelo Maggio2, Christian Bracco2, Matteo Poli2, Davide Di Spirito2, Pietro Gabriele3, Michele Stasi2.   

Abstract

The gamma index pass rate (%GP) of 384 helical Tomotherapy pre-patient quality assurance, acquired with ArcCHECK, is presented, analyzed, and correlated to plan characteristics. Average %GP was higher than 90% and correlated strongly with gamma method, irradiated length, pitch, maximum dose to diodes, and dose per fraction.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Gamma index metric; Quality assurance; Tomotherapy

Mesh：

Year:  2016        PMID： 26778646     DOI： 10.1016/j.radonc.2015.12.021

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  2 in total

1.  On the complexity of helical tomotherapy treatment plans.

Authors:  Tania Santos; Tiago Ventura; Josefina Mateus; Miguel Capela; Maria do Carmo Lopes
Journal:  J Appl Clin Med Phys       Date:  2020-05-04       Impact factor: 2.102

2.  Analysis of clinical patient-specific pre-treatment quality assurance with the new helical tomotherapy platform, following the AAPM TG-218 report.

Authors:  Marco Fusella; Samuele Cavinato; Alessandra Germani; Marta Paiusco; Nicola Pivato; Marco Andrea Rossato; Anthony Scott; Alessandro Scaggion
Journal:  Radiat Oncol       Date:  2021-11-22       Impact factor: 3.481
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.